Skip to Content Skip to Content
Articles from Steve Graff
Penn Medicine Researchers Find Much Stronger Association Between Alcohol Use and Advanced Liver Fibrosis in Patients Compared to Uninfected

Penn Medicine Researchers Find Much Stronger Association Between Alcohol Use and Advanced Liver Fibrosis in Patients Compared to Uninfected

Consumption of alcohol has long been associated with an increased risk of advanced liver fibrosis, but a new study published in the May issue of Clinical Infectious Diseases from researchers at Penn Medicine and other institutions shows that association is drastically heightened in people co-infec

Steve Graff

Penn Medicine Study: Sorafenib Shows Success in Advanced Differentiated Thyroid Cancer Patients

Penn Medicine Study: Sorafenib Shows Success in Advanced Differentiated Thyroid Cancer Patients

The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania published in the journal Lancet. This is the first effective treatment for thyroid cancer patients who progress following standard treatments.

Steve Graff

Radiation Oncologists at Penn's Abramson Cancer Center Say Model Will Preserve Access to Technology and Propel Research

Radiation Oncologists at Penn's Abramson Cancer Center Say Model Will Preserve Access to Technology and Propel Research

Proton therapy is in the proverbial chicken or the egg scenario.  Companies are pulling back on reimbursements to treat some cancers—notably prostate, breast and lung—because of the added expense and limited evidence to back it up.

Steve Graff

Penn Medicine First to Investigate Shared Decision Making in Radiation Oncology

Penn Medicine First to Investigate Shared Decision Making in Radiation Oncology

Playing an active role in their radiation treatment decisions leaves cancer patients feeling more satisfied with their care, and may even relieve psychological distress around the experience, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the

Steve Graff

Penn Study: Hepatitis C Remains Major Problem for HIV Patients Despite Antiretroviral Therapy

Penn Study: Hepatitis C Remains Major Problem for HIV Patients Despite Antiretroviral Therapy

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from antiretroviral therapy (ART) to treat HIV.

Steve Graff

Nicotine Withdrawal Weakens Brain Connections Tied to Self-Control Over Cigarette Cravings, Penn Study Finds

Nicotine Withdrawal Weakens Brain Connections Tied to Self-Control Over Cigarette Cravings, Penn Study Finds

People who try to quit smoking often say that kicking the habit makes the voice inside telling them to light up even louder, but why people succumb to those cravings so often has never been fully understood.  Now, a new brain imaging study in this week’s JAMA Psychiatry from scientists in Penn Medicine and the National Institute on Drug Abuse (NIDA) Intramural Research Program sh

Steve Graff

Penn Medicine: Personalized Gene Therapy Locks Out HIV, Paving the Way to Control Virus Without Antiretroviral Drugs

Penn Medicine: Personalized Gene Therapy Locks Out HIV, Paving the Way to Control Virus Without Antiretroviral Drugs

University of Pennsylvania researchers have successfully genetically engineered the immune cells of 12 HIV positive patients to resist infection, and decreased the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely—including one patient whose levels became undetectable.

Steve Graff

Load More